Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteogenomics | 14 | 2024 | 68 | 3.680 |
Why?
|
| Endometrial Neoplasms | 2 | 2023 | 98 | 1.400 |
Why?
|
| Exosomes | 3 | 2018 | 44 | 0.790 |
Why?
|
| Metformin | 1 | 2023 | 152 | 0.740 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2024 | 158 | 0.700 |
Why?
|
| Enteritis | 1 | 2020 | 54 | 0.650 |
Why?
|
| Neoplasms | 6 | 2024 | 2780 | 0.640 |
Why?
|
| Proteomics | 10 | 2024 | 501 | 0.630 |
Why?
|
| Proteome | 2 | 2021 | 243 | 0.630 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2021 | 240 | 0.590 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 248 | 0.570 |
Why?
|
| Biomedical Research | 1 | 2023 | 519 | 0.570 |
Why?
|
| Carcinoma | 1 | 2020 | 287 | 0.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2024 | 1892 | 0.540 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 920 | 0.470 |
Why?
|
| Transcriptome | 2 | 2021 | 953 | 0.460 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 1290 | 0.450 |
Why?
|
| RNA | 1 | 2016 | 571 | 0.420 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 702 | 0.400 |
Why?
|
| Antigens, Neoplasm | 3 | 2024 | 385 | 0.380 |
Why?
|
| Phosphorylation | 6 | 2021 | 1631 | 0.290 |
Why?
|
| Drugs, Chinese Herbal | 2 | 2023 | 19 | 0.280 |
Why?
|
| MicroRNAs | 3 | 2020 | 838 | 0.280 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 276 | 0.270 |
Why?
|
| Muscle Proteins | 2 | 2021 | 417 | 0.250 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 2509 | 0.240 |
Why?
|
| Molecular Targeted Therapy | 3 | 2024 | 361 | 0.230 |
Why?
|
| Humans | 30 | 2024 | 124705 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 488 | 0.220 |
Why?
|
| Bayes Theorem | 1 | 2024 | 284 | 0.210 |
Why?
|
| Ginsenosides | 1 | 2023 | 21 | 0.210 |
Why?
|
| Acetylation | 2 | 2021 | 164 | 0.210 |
Why?
|
| Protein Isoforms | 1 | 2023 | 404 | 0.200 |
Why?
|
| Mass Spectrometry | 1 | 2023 | 330 | 0.200 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2021 | 216 | 0.190 |
Why?
|
| beta Catenin | 1 | 2023 | 203 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2020 | 1243 | 0.190 |
Why?
|
| Liver X Receptors | 1 | 2021 | 18 | 0.190 |
Why?
|
| Radiation Injuries | 1 | 2023 | 142 | 0.190 |
Why?
|
| Foam Cells | 1 | 2021 | 21 | 0.190 |
Why?
|
| Cell Communication | 2 | 2021 | 166 | 0.190 |
Why?
|
| RNA, Messenger | 4 | 2023 | 2821 | 0.180 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2021 | 22 | 0.180 |
Why?
|
| Gene Editing | 1 | 2023 | 187 | 0.180 |
Why?
|
| Rats | 4 | 2020 | 3728 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2023 | 319 | 0.170 |
Why?
|
| Algorithms | 2 | 2024 | 1625 | 0.170 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 69 | 0.170 |
Why?
|
| Receptor, ErbB-2 | 2 | 2020 | 514 | 0.160 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 154 | 0.160 |
Why?
|
| Signal Transduction | 6 | 2021 | 4534 | 0.160 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 236 | 0.160 |
Why?
|
| Trastuzumab | 1 | 2020 | 134 | 0.160 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 117 | 0.160 |
Why?
|
| Th17 Cells | 1 | 2020 | 91 | 0.160 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 221 | 0.160 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 42 | 0.160 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 10 | 0.150 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 369 | 0.150 |
Why?
|
| Genomic Instability | 1 | 2020 | 229 | 0.150 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 2018 | 8 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2020 | 701 | 0.150 |
Why?
|
| Biomarkers, Tumor | 2 | 2023 | 1492 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 218 | 0.150 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 58 | 0.150 |
Why?
|
| Extracellular Vesicles | 1 | 2018 | 46 | 0.150 |
Why?
|
| Pyruvic Acid | 1 | 2018 | 38 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 357 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 66 | 0.140 |
Why?
|
| Protective Agents | 1 | 2018 | 35 | 0.140 |
Why?
|
| Animals | 9 | 2023 | 34235 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 355 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2020 | 333 | 0.140 |
Why?
|
| Drug Carriers | 1 | 2018 | 100 | 0.140 |
Why?
|
| Burns | 1 | 2018 | 77 | 0.140 |
Why?
|
| Cell Proliferation | 4 | 2019 | 2303 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2021 | 330 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2018 | 128 | 0.140 |
Why?
|
| Macrophages | 1 | 2021 | 621 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 191 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 294 | 0.130 |
Why?
|
| Female | 10 | 2023 | 66577 | 0.130 |
Why?
|
| Neointima | 1 | 2016 | 43 | 0.130 |
Why?
|
| Mice | 7 | 2023 | 17645 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 673 | 0.130 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 213 | 0.130 |
Why?
|
| Apoptosis | 3 | 2021 | 1802 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 691 | 0.120 |
Why?
|
| Astragalus Plant | 1 | 2014 | 2 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 663 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2023 | 6132 | 0.120 |
Why?
|
| Hepatic Stellate Cells | 1 | 2014 | 20 | 0.120 |
Why?
|
| Sesquiterpenes | 1 | 2014 | 25 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 3344 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 1023 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2014 | 140 | 0.110 |
Why?
|
| Mutation | 4 | 2021 | 5845 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2021 | 920 | 0.110 |
Why?
|
| Immunotherapy | 3 | 2024 | 675 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 576 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 1215 | 0.090 |
Why?
|
| Organophosphonates | 1 | 2011 | 20 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 882 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1660 | 0.090 |
Why?
|
| Peptides | 2 | 2024 | 810 | 0.090 |
Why?
|
| Adenine | 1 | 2011 | 103 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 635 | 0.090 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 130 | 0.090 |
Why?
|
| Hepatitis B, Chronic | 1 | 2011 | 79 | 0.090 |
Why?
|
| Genomics | 3 | 2023 | 1501 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 6584 | 0.080 |
Why?
|
| Retinoblastoma Protein | 2 | 2020 | 78 | 0.080 |
Why?
|
| Glycolysis | 2 | 2021 | 150 | 0.080 |
Why?
|
| Protein Kinases | 2 | 2021 | 332 | 0.080 |
Why?
|
| Hemorrhagic Fever with Renal Syndrome | 1 | 2008 | 1 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 2048 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 832 | 0.070 |
Why?
|
| Carotid Artery Injuries | 2 | 2019 | 40 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 539 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2008 | 124 | 0.070 |
Why?
|
| Metabolomics | 2 | 2021 | 423 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2016 | 2594 | 0.070 |
Why?
|
| Biological Transport | 2 | 2018 | 355 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 4396 | 0.060 |
Why?
|
| HLA-A2 Antigen | 1 | 2024 | 26 | 0.060 |
Why?
|
| Aged | 5 | 2021 | 19830 | 0.060 |
Why?
|
| Middle Aged | 6 | 2021 | 26884 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2023 | 36 | 0.050 |
Why?
|
| Actins | 2 | 2016 | 345 | 0.050 |
Why?
|
| Adult | 6 | 2021 | 29554 | 0.050 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 16 | 0.050 |
Why?
|
| NFI Transcription Factors | 1 | 2023 | 50 | 0.050 |
Why?
|
| Neurofibromin 1 | 1 | 2023 | 41 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 89 | 0.050 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 21 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2023 | 110 | 0.050 |
Why?
|
| Carboplatin | 1 | 2022 | 76 | 0.050 |
Why?
|
| Male | 8 | 2021 | 61317 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 4799 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2021 | 18 | 0.050 |
Why?
|
| Tristetraprolin | 1 | 2021 | 6 | 0.050 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 34 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2021 | 41 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2021 | 58 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 38 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 335 | 0.050 |
Why?
|
| Phospholipase C gamma | 1 | 2021 | 19 | 0.050 |
Why?
|
| APOBEC Deaminases | 1 | 2020 | 6 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2021 | 293 | 0.040 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2021 | 22 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 410 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2021 | 168 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2023 | 253 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 341 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 397 | 0.040 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 30 | 0.040 |
Why?
|
| Cell Line | 2 | 2015 | 2756 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2021 | 440 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 795 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 345 | 0.040 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2019 | 36 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2021 | 281 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 418 | 0.040 |
Why?
|
| Microsatellite Instability | 1 | 2019 | 36 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2021 | 370 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 54 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2018 | 48 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 21 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2019 | 295 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 2018 | 35 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2021 | 526 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2018 | 63 | 0.040 |
Why?
|
| Ribosomes | 1 | 2018 | 137 | 0.040 |
Why?
|
| DNA Damage | 1 | 2020 | 513 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 429 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 1752 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 585 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 670 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 441 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 556 | 0.030 |
Why?
|
| Polymerization | 1 | 2016 | 13 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 1062 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2016 | 19 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2019 | 460 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2016 | 21 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 678 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2018 | 554 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 1708 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 397 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 684 | 0.030 |
Why?
|
| Computational Biology | 1 | 2021 | 810 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1252 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1396 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 846 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1695 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 573 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2014 | 66 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 1274 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 664 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 129 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 281 | 0.030 |
Why?
|
| Critical Illness | 1 | 2018 | 599 | 0.030 |
Why?
|
| Aorta | 1 | 2016 | 547 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 812 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4620 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 867 | 0.020 |
Why?
|
| Glucose | 1 | 2016 | 879 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4258 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 1440 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2016 | 640 | 0.020 |
Why?
|
| Insulin | 1 | 2016 | 1204 | 0.020 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 46 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2011 | 185 | 0.020 |
Why?
|
| Kidney | 1 | 2018 | 1367 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 3055 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2524 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 157 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 210 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2008 | 79 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9023 | 0.020 |
Why?
|
| Creatinine | 1 | 2008 | 391 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 2558 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 775 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12364 | 0.010 |
Why?
|
| Adolescent | 1 | 2008 | 19221 | 0.010 |
Why?
|